202 related articles for article (PubMed ID: 25178484)
41. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
42. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
Niemeyer CM; Kang MW; Shin DH; Furlan I; Erlacher M; Bunin NJ; Bunda S; Finklestein JZ; Gorr TA; Mehta P; Schmid I; Kropshofer G; Corbacioglu S; Lang PJ; Klein C; Schlegel PG; Heinzmann A; Schneider M; Starý J; van den Heuvel-Eibrink MM; Hasle H; Locatelli F; Sakai D; Archambeault S; Chen L; Russell RC; Sybingco SS; Ohh M; Braun BS; Flotho C; Loh ML
Nat Genet; 2010 Sep; 42(9):794-800. PubMed ID: 20694012
[TBL] [Abstract][Full Text] [Related]
43. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
Liang Y; Kurakin A; Roizman B
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
[TBL] [Abstract][Full Text] [Related]
44. USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics.
Niño CA; Wollscheid N; Giangreco G; Maspero E; Polo S
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202887
[TBL] [Abstract][Full Text] [Related]
45. cbl-b inhibits epidermal growth factor receptor signaling.
Ettenberg SA; Keane MM; Nau MM; Frankel M; Wang LM; Pierce JH; Lipkowitz S
Oncogene; 1999 Mar; 18(10):1855-66. PubMed ID: 10086340
[TBL] [Abstract][Full Text] [Related]
46. [Ubiquitination-mediated degradation of epidermal growth factor receptor].
Xiu X; Lü ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):120-7. PubMed ID: 15782507
[TBL] [Abstract][Full Text] [Related]
47. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
[TBL] [Abstract][Full Text] [Related]
48. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.
Soubeyran P; Kowanetz K; Szymkiewicz I; Langdon WY; Dikic I
Nature; 2002 Mar; 416(6877):183-7. PubMed ID: 11894095
[TBL] [Abstract][Full Text] [Related]
49. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Habib AA; Chun SJ; Neel BG; Vartanian T
Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
[TBL] [Abstract][Full Text] [Related]
50. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
[TBL] [Abstract][Full Text] [Related]
51. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
Ji J; Navid F; Hiemenz MC; Kaneko M; Zhou S; Saitta SC; Biegel JA
Cancer Genet; 2019 Feb; 231-232():62-66. PubMed ID: 30803559
[TBL] [Abstract][Full Text] [Related]
52. Abi-1 forms an epidermal growth factor-inducible complex with Cbl: role in receptor endocytosis.
Tanos BE; Pendergast AM
Cell Signal; 2007 Jul; 19(7):1602-9. PubMed ID: 17395426
[TBL] [Abstract][Full Text] [Related]
53. Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations.
Bülow L; Lissewski C; Bressel R; Rauch A; Stark Z; Zenker M; Bartsch O
Am J Med Genet A; 2015 Feb; 167A(2):394-9. PubMed ID: 25358541
[TBL] [Abstract][Full Text] [Related]
54. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S
Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550
[TBL] [Abstract][Full Text] [Related]
55. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
[TBL] [Abstract][Full Text] [Related]
56. Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy.
Altmüller F; Pothula S; Annamneedi A; Nakhaei-Rad S; Montenegro-Venegas C; Pina-Fernández E; Marini C; Santos M; Schanze D; Montag D; Ahmadian MR; Stork O; Zenker M; Fejtova A
PLoS Genet; 2017 Mar; 13(3):e1006684. PubMed ID: 28346493
[TBL] [Abstract][Full Text] [Related]
57. RAS diseases in children.
Niemeyer CM
Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
[TBL] [Abstract][Full Text] [Related]
58. Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.
Rush JS; Boeving MA; Berry WL; Ceresa BP
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4691-9. PubMed ID: 24985478
[TBL] [Abstract][Full Text] [Related]
59. Graf regulates hematopoiesis through GEEC endocytosis of EGFR.
Kim S; Nahm M; Kim N; Kwon Y; Kim J; Choi S; Choi EY; Shim J; Lee C; Lee S
Development; 2017 Nov; 144(22):4159-4172. PubMed ID: 28993397
[TBL] [Abstract][Full Text] [Related]
60. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor.
Su X; Kong C; Stahl PD
J Biol Chem; 2007 Jul; 282(29):21278-84. PubMed ID: 17545148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
